XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 01, 2023
Jun. 25, 2022
Operating Activities:    
Net income $ 490,266 $ 469,464
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 64,816 58,986
Amortization 22,788 23,870
Gain on sale or disposal of property and equipment (124) (1,666)
Unrealized foreign currency (gains) losses (13,054) 21,217
Deferred income taxes (68,859) (66,382)
Stock compensation expense 43,397 39,755
Realized loss on marketable securities 59 773
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts (62,832) 122,428
Inventories 111,531 (294,766)
Other current and non-current assets 2,769 775
Accounts payable 45,206 (29,829)
Other current and non-current liabilities (39,484) (74,273)
Deferred revenue 4,711 (4,246)
Deferred costs (990) 2,920
Income Taxes (47,288) (3,550)
Net cash provided by operating activities 552,912 265,476
Investing activities:    
Purchases of property and equipment (99,346) (134,798)
Proceeds from sale of property and equipment 152 1,672
Purchase of intangible assets (847) (887)
Purchase of marketable securities (68,978) (873,110)
Redemption of marketable securities 98,885 620,796
Acquisitions, net of cash acquired   (10,828)
Net cash used in investing activities (70,134) (397,155)
Financing activities:    
Dividends (279,442) (258,249)
Proceeds from issuance of treasury stock related to equity awards 21,946 41,050
Purchase of treasury stock related to equity awards (9,397) (14,722)
Purchase of treasury stock under share repurchase plan (70,181) (25,117)
Net cash used in financing activities (337,074) (257,038)
Effect of exchange rate changes on cash and cash equivalents 599 (21,999)
Net increase (decrease) in cash, cash equivalents, and restricted cash 146,303 (410,716)
Cash, cash equivalents, and restricted cash at beginning of period 1,279,912 1,498,843
Cash, cash equivalents, and restricted cash at end of period $ 1,426,215 $ 1,088,127